BD Marks 65 Years In Canaan, Pours $34M Into Syringe Plant

BD, the medical technology company formally known as Becton, Dickinson and Company, said on Oct. 6, 2026 that it has reached 65 years of production at its plant in Canaan, Conn., and has put more than $34 million into the site over the past five years, according to a company announcement distributed by PR Newswire.

The spending covered three additional syringe production lines plus equipment upgrades intended to expand capacity and shore up supply, the company said.

The Canaan operation began in 1961 with eight workers in a 25,000-square-foot building that turned out roughly 10 million syringes annually. BD said the facility now covers 385,000 square feet, employs more than 500 people and produces upward of 2 billion syringes a year. More than 50 workers there have logged at least 25 years with the company, including 10 at 40 years or more.

BD describes the plant as the place where the first sterile, single-use plastic syringe was developed, replacing reusable glass models. Eric Borin, the company's worldwide president for Medication Delivery Solutions, said the device now "touching 80 patients every second."

Gov. Ned Lamont, state Rep. Maria Horn and state Sen. Stephen Harding issued statements praising the plant's role in the regional economy. BD also said it would give $10,000 to the Community Health & Wellness Center, bringing its support for the health center since 2024 to $90,000.

This story was first reported by PR Newswire.